Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...
“Whilst the decision to extend PNGRU’s suspension is disappointing, it is important that the independent panel be afforded every opportunity to diligently complete a fair review, given the importance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback